Clinical application value of combination detection of serum anti-CCP antibody and anti-AKA antibody for rheumatoid arthritis
10.3969/j.issn.1673-4130.2016.16.031
- VernacularTitle:血清抗CCP抗体和抗 AKA 抗体联合检测对类风湿关节炎的诊断价值
- Author:
Penghui TAO
- Publication Type:Journal Article
- Keywords:
rheumatoid arthritis;
anti-cyclic citrullinated peptide antibody;
anti-keratin antibody;
indirect immunofluores-cence
- From:
International Journal of Laboratory Medicine
2016;37(16):2285-2286
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the sensitivity and specificity of anti‐cyclic citrullinated peptide antibody (anti‐CCP antibody) and anti‐keratin antibody (anti‐AKA antibody) detection for diagnosing rheumatoid arthritis (RA) and the application value of their combination detection in the diagnosis and treatment of RA .Methods The chemiluminescent microparticle immunoassay and indi‐rect immunofluorescence analysis were adopted to detect anti‐CCP antibody and anti‐AKA antibody in 80 cases of RA ,40 cases of other auto‐immune diseases(AID) and 30 people undergoing the physical examination .Results The positive rates of anti‐CCP anti‐body and anti‐AKA antibody in the RA group were significantly higher than those in the non‐RA group and control group ,the differences were statistically significant (P< 0 .05) .The sensitivity of single anti‐CCP antibody detection in the RA group was 73 .8% ,which was higher than 41 .3% of anti‐AKA antibody ,while the specificity of single anti‐CCP antibody detection was 86 .2% ,which was lower than 95 .7% of anti‐AKA antibody detection .In their combined detection ,the sensitivity and specificity were increased .Conclusion The anti‐CCP antibody detection has higher sensitivity and specificity for diagnosing RA .Its combined detection with anti‐AKA antibody can avoid the missed diagnosis of atypical clinical early stage RA ,which has a higher clinical value in the diagnosis and prognosis of RA .
